[The effect of immunotherapy and hyperthermia on advanced or recurrent ovarian and uterine cancer – 229 clinical cases]
/in Endometrial Cancer, International Publications, Ovarian CancerHyperthermia induces apoptosis through endoplasmic reticulum and reactive oxygen species in human osteosarcoma cells
/in Hyperthermia, International PublicationsRandomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer
/in Dendritic Cells, International Publications, NSCLCDendritic cell-based vaccine for the treatment of malignant glioma: a systematic review
/in Glioblastoma, International PublicationsThermotolerance induced at a mild temperature of 40°C alleviates heat shock-induced ER stress and apoptosis in HeLa cells
/in Hyperthermia, International PublicationsIntravenously injected Newcastle disease virus in non-human primates is safe to use for oncolytic virotherapy
/in International Publications, Newcastle Disease VirusEffect of recombinant Newcastle disease virus transfection on lung adenocarcinoma A549 cells
/in International Publications, Newcastle Disease Virus, NSCLCMiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells
/in Glioblastoma, International PublicationsRadiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response
/in Dendritic Cells, Hypernephroma, International Publications, Malignant MelanomaIMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer